Thrombotic Microangiopathy with Skin Localization Secondary to Cytarabine-Daunorubicin Association: Report of a Case
The thrombotic microangiopathy is a syndrome characterized by the combination of mechanical hemolytic anemia, peripheral thrombocytopenia, and organ failure of variable severity. In addition to the idiopathic form, several cases are identified as secondary to pregnancy, infections, disease systems,...
Saved in:
| Main Authors: | S. Regragui, S. Amelal, S. Astati, M. Zine, N. Alami Drideb, A. Al Bouzidi, N. Messaoudi, M. Benkirane, K. Doghmi, M. Mikdame |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Case Reports in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2012/806476 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Clinical Safety and Efficacy of Cytarabine and Daunorubicin Liposome (CPX‐351) in Acute Myeloid Leukemia Patients: A Systematic Review
by: Abdulwahab M. Alzahrani, et al.
Published: (2025-05-01) -
COVID-19 and thrombotic microangiopathy
by: E. V. Sluhanchuk, et al.
Published: (2022-01-01) -
Pseudo-Thrombotic Microangiopathy Secondary to Vitamin B12 Deficiency
by: Dylan Morrissey, et al.
Published: (2022-01-01) -
Thrombotic Microangiopathy Secondary to Sirolimus Monotherapy in Orthotopic Liver Transplant
by: Tabeer Rana, et al.
Published: (2024-06-01) -
Clinical case of thrombotic microangiopathy in obstetric practice
by: M. N. Mochalova, et al.
Published: (2017-06-01)